News Articles
Browse our entire archive of news articles, spotlight interviews, and other editorial pieces in one place.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Filters
Tag
Entheon Biomedical Provides Update on Centre for Human Drug Research License Amendments
Entheon Biomedical
MindMed Streamlines Leadership with Further Emphasis on Integrating Psychedelic Drug Development with Digital Medicines and Therapeutics
Mind Medicine (MindMed)
Mindset Selects Compounds from Its Third Psilocybin-Inspired Drug Family to Move into in vivo PoC Studies
Mindset Pharma
Mydecine Innovations Group Receives Conditional Approval to List on NEO Exchange
Mydecine Innovations Group
Jeff Siegel | Managing Partner, JLS Fund
No items found.
Novamind to Present at Canaccord Genuity Conference: "New Paradigms & Treatment Approaches in Mental Health"
Novamind Inc.
Psyence Group Completes First Cultivation Cycle of Medical Psilocybin Mushrooms at Its Commercially Licensed Facility
Psyence Group
COMPASS Pathways plc to participate in Canaccord Genuity's New Paradigms and Treatment Approaches in Mental Health Conference
Compass Pathways
Mydecine Innovations Group Sponsors Study on Neuron Level Response to Psilocybin at University of Maryland
Mydecine Innovations Group
Horizons Psychedelic ETF ($PSYK) Holdings - January 27, 2021
No items found.
Get the Headlines & Market Updates
Be the first to see new company features, exclusive interviews and breaking news. Subscribe now.